
Sign up to save your podcasts
Or


Send us Fan Mail
DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025.Ā As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the United States, effective close of business Tuesday, July 22, 2025."
šļø When Hope Collides with Risk: Sareptaās Gene Therapy Crisis
In this episode of Petri Dish Perspectives,Ā Manead goes off-script to unpack one of the hottest biotech stories in the headlines today: the unraveling of Sarepta Therapeutics.
What began in a small Oregon lab in 1980 as Antivirals Inc. evolved into Sarepta, a pioneer in the fight against Duchenne muscular dystrophy (DMD). From early exon-skipping breakthroughs to the dazzling promise of its gene therapy, Elevidys, Sarepta has long been a symbol of hope for families facing an otherwise devastating disease.
But in 2025, that hope hit a hard wall: patient deaths, regulatory clashes, and a growing crisis thatās shaking confidence in gene therapy as a whole. In under 30 minutes, Manead breaks down Sareptaās 40-year journey, the science, the promise, the standoff with the FDAĀ and what this turning point means for the future of genetic medicine.
This isnāt just another biotech update, itās a raw look at what happens when cutting-edge hope meets the harsh edge of reality.
Grab your coffee or tea, hit play, and stay curious.
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#Biotech #GeneTherapy #Sarepta #DMD #FDA #RareDisease #PetriDishPerspectives #BiotechUnleashed
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
š¬āØ From Cystic Fibrosis Breakthroughs to Gene Editing Cures
In this episode of Petri Dish Perspectives: Biotech Unleashed, Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition and why theyāre now tackling sickle cell, diabetes, and more with CRISPR and stem cell science.
Discover how visionary chemists, Nobel-winning gene editors, and patient advocates built one of biotechās most inspiring success stories, proving that deep science and real patient impact can go hand in hand.
Grab your coffee and hit play! š
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#Biotech #VertexPharma #CRISPR #GeneEditing #CysticFibrosis #RareDisease #HealthcareInnovation #PetriDishPerspectives #BiotechPodcast
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
𧬠From VC to Blockbusters: The Genentech Story
In Episode 11 of Petri Dish Perspectives: Biotech Unleashed, host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its humble beginnings in a borrowed lab to pioneering insulin, tPA, Herceptin, and more, learn how Genentech turned recombinant DNA into real-world cures. Discover the bold VC bets, game-changing antibodies, and the Roche acquisition that preserved its science-first culture. A must-listen for biotech nerds and curious minds alike!
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#Genentech #BiotechPodcast #Herceptin #Avastin #Rituxan #RecombinantDNA #OncologyInnovation #PetriDishPerspectives #HealthcareInnovation #PharmaHistory #RocheGroup #StartupToSuperpower
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
š” From Vitamin C to AI-Driven Diagnostics: Rocheās Legacy Unleashed
In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss chemical company to becoming a global leader in pharmaceuticals and diagnostics.
Youāll hear how Roche launched the worldās first branded vitamin C, pioneered molecular diagnostics with PCR, and laid the groundwork for todayās precision medicine revolution. Weāll also dive into how Rocheās unique dual-engine modelādrugs + diagnostics, that helped shape modern healthcare.
Whether you're a biotech nerd or just curious about the science behind your health, this episode is packed with insight, history, and a glimpse into Rocheās future.
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#Roche #Biotech #Diagnostics #VitaminC #PCR #PrecisionMedicine #HealthcareInnovation #PharmaGiants #PetriDishPerspectives #BiotechPodcast
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
š§ From Dye Pots to Blockbusters: The Bayer Story
In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you on a journey through Bayerās 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin š, Xarelto ā¤ļø, and Eylea šļø. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing invention of Aspirin, blockbuster therapies, the turbulent Monsanto acquisition š¾āļø, and the companyās high-stakes reinvention under CEO Bill Anderson.
𧬠Science, strategy, and resilience ā Bayerās story is biotech history in motion.
šļø Tune in for a 30-min deep dive into one of the worldās most iconic life science companies.
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#Bayer #Biotech #PetriDishPerspectives #BiotechPodcast #ScienceStorytelling #BillAnderson #HealthcareLeadership
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) ā from 19th-century Brooklyn apothecaries and sparkling laxatives š to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment š§«š„.
Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down:
š The parallel founding stories of E.R. Squibb & Sons and Bristol-Myers
Ā š§ The game-changing 1989 merger that created BMS
Ā ā¤ļø Blockbuster hits in cardiovascular health (Plavix, anyone?)
Ā š§Ŗ The leap into immuno-oncology with Opdivo and Yervoy
š§² The bold $74B acquisition of Celgene ā and how it supercharged BMSās cell therapy pipeline
š Whatās next in AI-driven R&D, off-the-shelf CAR-Ts, and more
If youāre curious how a legacy pharma reinvented itself into an oncology and biotech juggernaut, this episode is for you.
Grab your favorite drink and tune in to explore the science, the strategy, and the standout leaders behind BMS.
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#PetriDishPerspectives #BiotechUnleashed #BMS #Immunotherapy #CAR_T #PharmaHistory #Oncology #BiotechPodcast
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
Ever wonder how an oil conglomerate helped create one of the worldās top pharma giants? š„ In this episode of Petri Dish Perspectives: Biotech Unleashed, your host, Manead, dives into the fascinating story of Sanofi, a company whose name youāve probably seen on insulin pens š, flu shots š¦ , and blockbuster immunology meds š.
We explore:
Ā š¹ Sanofiās wild beginnings inside a French oil giant š¢ļø
Ā š¹ Game-changing acquisitions ā Aventis, Genzyme, and more šø
Ā š¹ Lantus and its dominance in diabetes care š§
Ā š¹ Vaccine legacy from Louis Pasteur to COVID-19 š§«
Ā š¹ The Dupixent boom and Regeneron partnership š¤
Ā š¹ Bold bets on mRNA 𧬠and AI š in drug discovery
Ā š¹ CEO Paul Hudsonās tech-first transformation š
Whether youāre into biotech strategy, pharma history, or future-forward science, this 30-minute episode has something for every science nerd and healthcare junkie out there š¬š”
Grab your favorite drink, hit play, and geek out with us!
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#biotech #pharma #Sanofi #healthcareinnovation #podcast #PetriDishPerspectives
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, we'll take you on a 350-year journey through the rise of Merck, from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the worldās most influential pharmaceutical powerhouses.
Weāll explore how Merck evolved through groundbreaking discoveries like streptomycin, the MMR vaccine, statins, and the game-changing cancer immunotherapy Keytruda. Youāll also hear about the incredible legacy of Dr. Maurice Hilleman, a vaccine pioneer whose work continues to save millions of lives today.
Along the way, we dive into Merckās unique split post-WWI, its relentless focus on science-first innovation, and its modern-day ventures in oncology, gene editing, and AI-driven drug discovery.
Whether youāre a biotech enthusiast, healthcare professional, or just curious about the companies shaping tomorrowās medicine, this episode packs powerful insights in under 30 minutes. Grab your coffee and settle in, this is Merck, unleashed.
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
š“ From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story š“
Welcome to Petri Dish Perspectives: Biotech Unleashed! š Iām your host, Maneadāscientist and biotech nerd.
Today, weāre spotlighting Boehringer Ingelheimāa family-owned pharma giant that began in a small German village and grew into one of the worldās top 20 pharmaceutical companies. From veterinary vaccines to life-saving treatments for respiratory disease, diabetes, and cancer, Boehringer has quietly shaped medicine for humans and animals alike.
Theyāve stayed private for over 135 yearsāwhatās their secret? How did a rural chemistās workshop become a global leader in immuno-oncology and regenerative medicine? And where is Boehringer placing its bets for the future?
Grab your notebookāor your favorite biotech-friendly beverageāand join me as we explore the fascinating rise of Boehringer Ingelheim. š
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J)āone of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids, Tylenol, and Johnsonās Baby Powder, J&J has shaped modern medicine in countless ways.
Weāll explore how Robert Wood Johnson I, alongside his brothers, turned a struggling startup into a global powerhouse by pioneering antiseptic surgical techniques, mass-market first-aid products, and cutting-edge medical devices. Along the way, weāll also discuss J&Jās resilience through major challengesālike the 1982 Tylenol crisis, which redefined corporate crisis management.
Fast forward to today, and J&J is still at the forefront of innovation, investing heavily in robotics, gene therapy, and AI-driven healthcare solutions.Ā
Grab a coffee and tune in for a fast-paced, insightful breakdown of J&J's journey!
š§ Listen now, stay curious, and donāt forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
Support the show
Ā© 2026 The Perspective Bureau LLC. All rights reserved.
From the publisher's feed
Burma | Chicago
Scientist š„¼š§Ŗš¬
Covering biotech, pharma, and healthcare companies shaping the world š§¬š„š
Stream new episodes everyā¦
https://linktr.ee/maneadkhin
#biotech #pharma #healthcare #podcast #petridishperspectives